1.0Journal of Lutheran Ethicshttps://learn.elca.org/jlerich600338<blockquote class="wp-embedded-content" data-secret="igExctZhrE"><a href="https://learn.elca.org/jle/acts-therapeutic-cloning-help-or-hype/">ACT’s “Therapeutic Cloning” — Help or Hype?</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://learn.elca.org/jle/acts-therapeutic-cloning-help-or-hype/embed/#?secret=igExctZhrE" width="600" height="338" title="“ACT’s “Therapeutic Cloning” — Help or Hype?” — Journal of Lutheran Ethics" data-secret="igExctZhrE" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script type="text/javascript"> /* <![CDATA[ */ /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); //# sourceURL=https://learn.elca.org/jle/wp-includes/js/wp-embed.min.js /* ]]> */ </script> [1] Our heated summer-time debates over human embryonic stem cell research were all but forgotten until we were jolted over the sleepy Thanksgiving weekend by an announcement from researchers at Advanced Cell Technology (ACT), a small biotech company in Massachusetts. On TV screens, in the pages of “U.S. News & World Report,” and online in […]https://learn.elca.org/jle/wp-content/uploads/sites/3/2021/01/Journal_of_Lutheran_Ethics_Logo.jpg250250